Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants |
Perphenazine for schizophrenia |
Perphenazine versus low-potency first-generation drugs for schizophrenia |
Persistence of immunoglobulin G after natural infection with SARS-CoV-2 |
Personal assistance for adults (19-64) with both physical and intellectual impairments |
Personal assistance for older adults without dementia |
Personal protective equipment for preventing asbestos exposure in workers |
Personalised interventions for children with conduct problems |
Personalised risk communication for informed decision making about taking screening tests |
Personally tailored activities for people with dementia in long-term care |
Personally tailored activities for people with dementia living in their own homes |
Pessaries (mechanical devices) for managing pelvic organ prolapse in women |
Pet allergen control measures for allergic asthma in children and adults |
PET-CT scanning to assess the spread of non-small cell lung cancer within the chest |
PETTICOAT technique versus standard TEVAR for complicated type B aortic dissection |
Pharmaceutical heroin for heroin maintenance in chronic heroin dependents |
Pharmaceutical policies: effects of policies that determine which drugs are reimbursed |
Pharmaceutical policies: effects of sales and dispensing policies |
Pharmaceutical policies: effects on rational drug use |
Pharmacies might be able to support people with their depression medicines |
Pharmacist-led interventions for adults with asthma or COPD |
Pharmacists play vital role in improving patient health shows biggest review of evidence to date |
Pharmacists providing prescribing advice and education to healthcare professionals in community, primary care and outpatient settings |
Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancer |
Pharmacologic interventions for pregnant women enrolled in alcohol treatment programs |
Pharmacologic interventions for preventing and treating periprosthetic osteoporosis following total hip arthroplasty |
Pharmacologic therapies for perioperative cerebral protection against neurologic or neurocognitive deficits |
Pharmacological agents as symptomatic treatment for memory disorder in people with multiple sclerosis |
Pharmacological and non-pharmacological interventions for symptomatic gastroparesis |
Pharmacological and non-pharmacological treatments for impulsive-compulsive behaviors in Parkinson's disease |
Pharmacological and psychological interventions for depression in people with tuberculosis |
Pharmacological and psychosocial interventions for night eating syndrome in adults |
Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients |
Pharmacological interventions for acute and transient psychotic disorder (ATPD) |
Pharmacological interventions for ADHD symptoms in children with fetal alcohol spectrum disorders (FASD) |
Pharmacological interventions for adjustment disorders in adults |
Pharmacological interventions for avoidant personality disorder |
Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings |
Pharmacological interventions for bone health in people with epilepsy |
Pharmacological interventions for clozapine-induced sinus tachycardia |
Pharmacological interventions for depression in adults with chronic hepatitis B or C |
Pharmacological interventions for depression in people with traumatic brain injury |
Pharmacological interventions for drug-using offenders |
Pharmacological interventions for epilepsy in people with intellectual disability |
Pharmacological interventions for hypertensive emergencies |
Pharmacological interventions for improving respiratory symptoms and function in amyotrophic lateral sclerosis |
Pharmacological interventions for jet lag |
Pharmacological interventions for obsessive-compulsive personality disorder |
Pharmacological interventions for pain in patients with temporomandibular disorders |
Pharmacological interventions for painful persistent temporomandibular disorders (TMD) |
Pharmacological interventions for paranoid personality disorder |
Pharmacological interventions for people with histrionic personality disorder |
Pharmacological interventions for people with narcissistic personality disorder |
Pharmacological interventions for preventing bone density loss in critically ill people |
Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy |
Pharmacological interventions for preventing complications in idiopathic hypercalciuria |
Pharmacological interventions for preventing contrast-induced nephropathy |
Pharmacological interventions for preventing recurrent urinary stones in adults and children |
Pharmacological interventions for preventing salivary gland dysfunction following radiotherapy |
Pharmacological interventions for reducing weight gain in schizophrenia |
Pharmacological interventions for reduction of weight gain in people with schizophrenia |
Pharmacological interventions for schizoid personality disorder |
Pharmacological interventions for schizotypal personality disorder |
Pharmacological interventions for self‐harm in adults |
Pharmacological interventions for the acute management of hyperkalaemia in adults |
Pharmacological interventions for the prevention and treatment of radiation colitis, enteritis and proctitis |
Pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated neonates |
Pharmacological interventions for the primary prevention of gallbladder stones in adults |
Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease |
Pharmacological interventions for the treatment of aortic root and heart valve disease |
Pharmacological interventions for the treatment of bleeding in people treated for blunt force or penetrating injury in an emergency department: a systematic review and network meta-analysis |
Pharmacological interventions for treating acute heterotopic ossification |
Pharmacological interventions for treating dyslipidemia in patients with HIV infection |
Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy |
Pharmacological interventions for vasoplegic syndrome after cardiac surgery |
Pharmacological interventions show potential for a protective role against ischaemia-reperfusion injury in liver resections |
Pharmacological interventions to decrease ischaemia reperfusion injury in liver transplantation |
Pharmacological interventions to prevent and treat upper gastrointestinal bleeding in neonates |
Pharmacological interventions to treat adults with cancer-related fatigue |
Pharmacological therapies for fibromyalgia (fibromyalgia syndrome) in adults - an overview of Cochrane Reviews |
Pharmacological therapies for maintenance treatments of opium dependence |
Pharmacological therapies for the prevention of fractures in men |
Pharmacological treatment (drugs) for Buerger's disease |
Pharmacological treatment for aphasia following stroke |
Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis |
Pharmacological treatment for continuous spike-wave during slow wave sleep syndrome and Landau-Kleffner syndrome |
Pharmacological treatment for Kleine-Levin syndrome |
Pharmacological treatment for muscle weakness and wasting in myotonic dystrophy |
Pharmacological treatment for psychotic depression |
Pharmacological treatment of depression in people with a primary brain tumour |
Pharmacological treatments for adults with overweight and obesity without diabetes |
Pharmacological treatments for chronic fatigue syndrome in adults |
Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysis |
Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis |
Pharmacological treatments for disordered and problem gambling |
Pharmacological treatments for fatigue associated with palliative care |
Pharmacological treatments for Friedreich ataxia |
Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews |
Pharmacological treatments for osteoporosis in patients with chronic kidney disease |
Pharmacological treatments for psychosis-related polydipsia |
Pharmacological treatments for vaccine-induced immune thrombocytopenia and thrombosis (VITT) after COVID-19 vaccination |
Pharmacological treatments in panic disorder in adults: a network meta-analysis |
Pharmacological treatments in panic disorder in adults: a network meta-analysis |
Pharmacological treatments in panic disorder in adults: a network meta-analysis |
Pharmacological treatments of postural hypotension |
Pharmacological, non-invasive brain stimulation and psychological interventions for treating depression after stroke |
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis |
Pharmacotherapy for Behcet's syndrome |
Pharmacotherapy for bipolar disorder in older people |
Pharmacotherapy for hypertension in adults 60 years or older |
Pharmacotherapy for hypertension in adults with obstructive sleep apnea |
Pharmacotherapy for resistant hypertension in adults |
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers |
Pharmacotherapy for tooth grinding or clenching during the sleep (sleep bruxism) |
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus |
Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome |
Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage |
Phenobarbitone versus phenytoin monotherapy (single-drug treatment) for epilepsy |
Phenytoin for neuropathic pain and fibromyalgia in adults |
Phlebotomy for hereditary haemochromatosis |
Phlebotonics for haemorrhoids |
Phonics training for English-speaking poor readers |
Phosphate binders to prevent complications of chronic kidney disease |
Phosphodiasterase III inhibitors for chronic asthma |
Phosphodiesterase 4 inhibitors for psoriatic arthritis |
Phosphodiesterase 5 (sildenafil) inhibitors for pulmonary hypertension |
Phosphodiesterase III inhibitor class drugs taken orally and long term are associated with increased deaths in heart failure |
Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus |
Phosphodiesterase inhibitors for treatment of urinary problems in men with benign prostatic hyperplasia |
Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension |
Phosphodiesterase-4 inhibitors for people with chronic obstructive pulmonary disease (COPD) |
Photodynamic therapy for recurrent respiratory papillomatosis |
Photodynamic therapy for treating age-related macular degeneration |
Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for correction of long-sightedness |
Phototherapy for treating foot ulcers in people with diabetes |
Phototherapy for treating pressure ulcers |
Phyllanthus species for chronic hepatitis B virus infection |
Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection |
Physical activity and exercise for chronic pain in adults - an overview of Cochrane Reviews |
Physical activity for improving cognition in older people with mild cognitive impairment |
Physical activity for improving the symptoms of attention deficit hyperactivity disorder in children and adolescents |
Physical activity for lower urinary tract symptoms due to benign prostatic obstruction |
Physical activity for preventing or managing osteoporosis in men |
Physical activity for the management of cancer-related fatigue in adults |
Physical activity for women with breast cancer who have completed active cancer treatment |
Physical activity interventions and nutrition-based interventions for children and adolescents with type 1 diabetes mellitus |
Physical activity interventions for people with congenital heart disease |
Physical activity interventions for the physical and mental health of people during and after treatment for bowel cancer |
Physical activity programs for older adults |
Physical activity programs for promoting bone mineralization and growth in preterm infants |
Physical activity to improve exercise capacity in people with cystic fibrosis |
Physical conditioning as part of a return to work strategy to reduce sickness absence for workers with back pain |
Physical environmental designs in residential care to improve quality of life of older people |
Physical examination for the diagnosis of lumbar radiculopathy due to disc herniation in patients with low-back pain and sciatica: a systematic review. |
Physical exercise as a treatment for sleep problems in older people |
Physical exercise for oppositional defiant disorder and conduct disorder in children and adolescents |
Physical exercise for people with Parkinson's disease: what type of exercise works best? |
Physical exercise for type 1 diabetes mellitus |
Physical exercise helps to improve symptoms of Parkinson’s Disease |
Physical exercise training for people with spinal muscular atrophy type 3 |
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer |
Physical exercise training to increase cardiorespiratory fitness in people with spinal cord injury |
Physical fitness training for people with spinal cord injury |
Physical fitness training for stroke survivors |
Physical health care monitoring for people with serious mental illness |
Physical interventions (orthoses, splints, exercise and manual therapy) for treating plantar heel pain |
Physical interventions for breathlessness in adults with advanced diseases |
Physical interventions for preventing stress fractures of the lower limbs |
Physical medicine modalities for mechanical neck disorders |
Physical methods for preventing deep vein thrombosis in stroke |
Physical methods for treating fever in children |
Physical rehabilitation approaches for recovery of function, balance and walking after stroke |
Physical rehabilitation for older people in long-term care |
Physical tests for diagnosing anterior cruciate ligament rupture |
Physical tests for shoulder impingement in primary care |
Physical therapies for postural abnormalities in people with cystic fibrosis |
Physical therapies for reducing and controlling lymphoedema of the limbs |
Physical therapy for the management of patients with temporomandibular disorders and related pain. |
Physical therapy interventions for pelvic girdle pain (PGP) after pregnancy |
Physical therapy interventions for the prevention of fractures after spinal cord injury |
Physical training for asthma |
Physical treatment interventions for managing spasticity after stroke |
Physical treatments for idiopathic facial paralysis |
Physician anaesthetists versus nurse anaesthetists for surgical patients |
Physician use of red flags to screen for cancer in patients with new back pain |
Physician use of red flags to screen for fractured vertebrae for patients with new back pain |
Physicians can be assisted in their delivery of preventive care services through group education, reminder devices and changes to the organisation of care |
Physiological track-and-trigger/early warning systems for use in maternity care |
Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage |
Physiotherapy and physiotherapeutical modalities for lateral epicondylitis |
Physiotherapy for ankylosing spondylitis |
Physiotherapy for the treatment of Parkinson's disease |
Physiotherapy for treatment of Parkinson's disease |
Phytoestrogens for vasomotor menopausal symptoms |
Phytoestrogens in the treatment of postmenopausal osteoporosis |
Phytomedicines (medicines derived from plants) for sickle cell disease |
Piggy-back method versus standard method of liver transplantation |
Pilates for low back pain |
Pimozide for schizophrenia or related psychoses |
Pimozide is an effective treatment for tics in Tourette Syndrome. |
Pioglitazone for adults with high risk of developing type 2 diabetes mellitus |
Pioglitazone for people with impaired glucose tolerance or impaired fasting blood glucose |
Pioglitazone for type 2 diabetes mellitus |
Piracetam for acute ischaemic stroke |
Piracetam for fetal distress in labour |
Piracetam for reducing the incidence of painful sickle cell disease crises |
Piribedil for levodopa-induced complications in Parkinson's disease |
Piribedil for symptomatic management of Parkinson's disease |
Piribedil versus levodopa in early Parkinson's disease |
Piroxicam as a single dose in treating acute postoperative pain |
Pitavastatin for lowering lipids |
Pivotal Response Treatment for autism spectrum disorder (ASD) |
Placebo interventions for all clinical conditions |
Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease |
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis |
Placebo versus no treatment for people with schizophrenia |
Placenta delivery at caesarean section |
Placental cord drainage after vaginal delivery as part of the management of the third stage of labour |
Planned abortion after three months of pregnancy can be done using several medicines. This review looked at which medical procedure is the best. |
Planned birth at or near term for improving health outcomes for pregnant women with pre-existing diabetes and their infants |
Planned birth at or near term for pregnant women with gestational diabetes and their infants |
Planned caesarean section for a twin pregnancy |
Planned caesarean section for term breech delivery |
Planned caesarean section versus planned vaginal birth for severe pre-eclampsia |
Planned elective repeat caesarean section versus planned vaginal birth for women with a previous caesarean birth |
Planned home versus hospital care for rupture of the membranes before 37 weeks' gestation |
Planned hospital birth versus planned home birth |
Planned relaparotomy versus relaparotomy on demand for treatment of secondary peritonitis |
Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
Plasma exchange for generalised myasthenia gravis |
Plasma exchange for Guillain-Barré syndrome |
Plasma exchange for multiple sclerosis |
Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis |
Plasma transfusion strategies for critically ill patients |
Plasma transfusion to prevent intraventricular haemorrhage in very preterm infants |
Plasma transfusions before major surgery (other than heart surgery) or invasive procedures, to prevent bleeding |
Plasma transfusions prior to insertion of central lines for people with abnormal coagulation |
Plasma transfusions prior to insertion of lumbar puncture needles for people with abnormal coagulation |
Plasma volume expansion for suspected impaired fetal growth |
Plasma volume expansion for treatment of pre-eclampsia |
Plasmakinetic resection versus transurethral resection of the prostate for benign prostatic hyperplasia |
Plastic stents versus fully covered self-expandable metallic stents for biliary tract strictures in adults with non-cancerous bile duct lesions |
Plastic stents versus metal stents for endoscopic ultrasound-guided transmural drainage of pancreatic fluid collections |
Platelet count, spleen length, and platelet-to-spleen length ratio for the diagnosis of oesophageal varices in people with liver disease |
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial treatment of acute coronary syndromes |
Platelet rich therapies for long bone healing in adult |
Platelet transfusion before surgery for people with low platelet counts |
Platelet transfusion thresholds for thrombocytopenic infants |
Platelet transfusions are used to prevent bleeding in patients with low platelet counts due to treatment-induced bone marrow failure |
Platelet transfusions are used to prevent bleeding in people with low platelet counts due to treatment-induced bone marrow failure |